BAG3 and glioblastoma: Notably, aggressive tumor subtypes, including anaplastic thyroid carcinoma and glioblastoma—which are characterized by therapy resistance and poor prognosis—demonstrate elevated BAG3 positivity, suggesting BAG3-driven mechanisms contribute to their aggressive phenotype.